Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07027657 · ClinicalTrials.gov registry record · NA
EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress
A NA study of Sleep Quality and Stress Reduction, sponsored by BTL Industries.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT07027657: Recruiting NA study of Sleep Quality and Stress Reduction, sponsored by BTL Industries.
NCT07027657 is a NA study of Sleep Quality and Stress Reduction that is actively recruiting participants, run by BTL Industries. The registered enrollment target is 60 participants, below the 98-participant average among 13 other Sleep Quality trials with a reported enrollment target (39% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07027657, a NA study of Sleep Quality and Stress Reduction, is actively recruiting participants, sponsored by BTL Industries.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to evaluate whether the treatment with BTL-699-2 device is able to improve sleep quality and reduce stress in adults above the age of 22 years. The main questions it aims to answer are: Does the treatment with BTL-699-2 device improve sleep quality? Does the treatment with BTL-699-2 device reduce stress? Participants will be asked to: * Undergo six treatments * Complete the Pittsburgh Sleep Quality Index * Complete the Perceived Stress Scale Questionnaire * Complete the Sleep and Stress Assessment Questionnaire * Complete the Therapy Comfort and Subject Satisfaction Questionnaire
Primary Outcome
The change in the score obtained from the Pittsburgh Sleep Quality Index will be recorded. The questionnaire will be administered at the baseline visit, after the last treatment, at the 1-month and 3-month follow-up visits. It is a 19-item questionnaire. These 19 questions are grouped into 7 components, and each component is scored on a 0 - 3 scale. The minimum obtained score is 0 and the maximum is 21. Lower score indicates healthier sleep quality, therefore improvement is considered a decrease
Conditions Studied
Interventions
- DEVICE Treatment with BTL-699-2
- DEVICE Treatment with BTL-699-2 (sham)
Study Locations (3)
California
- AntiAging and Wellness - Chula Vista
- Kind Health Group - Encinitas
Illinois
- Minooka Healthcare Center - Minooka
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-05-02 |
| Est. Completion | 2026-08-02 |
| Phase | NA |
What NCT07027657 shows while recruiting
NCT07027657 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 98-participant average among 13 other Sleep Quality trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Sleep Quality appearing as the primary indexed condition, and to 2 interventions - of which Treatment with BTL-699-2 is the first listed.
NCT07027657 reports a single indexed study location in California, Illinois.
Frequently Asked Questions
What is clinical trial NCT07027657 about?
NCT07027657 is a clinical study titled "EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress". The goal of this clinical trial is to evaluate whether the treatment with BTL-699-2 device is able to improve sleep quality and reduce stress in adults above the age of 22 years. The main questions it aims to answer are: Does the treatment with BTL-699-2 device improve sleep quality? Does the treat...
What is the current status of trial NCT07027657?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-02. Estimated completion is 2026-08-02.
What conditions does trial NCT07027657 study?
This clinical trial studies the following conditions: Sleep Quality, Stress Reduction.
What interventions are being tested in trial NCT07027657?
The interventions under investigation include: Treatment with BTL-699-2 (DEVICE), Treatment with BTL-699-2 (sham) (DEVICE).
Who is sponsoring clinical trial NCT07027657?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07027657 being conducted?
This trial has 3 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Quality
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07027657's enrollment target sits among peer trials
60 8th of 13 higher than 6 of 13 other Sleep Quality trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Quality trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity
RECRUITING · NA
-
The Effects of a Nutritional Supplement on Sleep Quality
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
-
A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children
RECRUITING · NA
-
Benefits of Nicotinamide Riboside Upon Cognition and Sleep
RECRUITING · NA
-
IMST for Dementia Risk Reduction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI